December Newsletter 2022
Posted by | Fuld & Company
Welcome to the last edition of our newsletter for 2022. Thank you for being a part of our community this year and I hope you enjoyed our newsletters!
This year, we featured the latest insights and perspectives from our experts to help our clients and community stay ahead of their competitors. Thank you to all those who contributed.
Fuld wishes you a very Happy Holiday Season and New Year! We look forward to the new year bringing much success and growth.
The Vaccine Race – Who is the Winner?
The race to find a vaccine for COVID-19 created many opportunities for pharmaceutical companies around the globe. While it was the major players who were ultimately responsible for achieving the breakthrough, smaller firms got a significant boost as well, building unique platforms and creating new product classes for use beyond the pandemic. Our article explores the fervent activities that enabled firms to wi n the Great Vaccine Race along with how unprecedented research funding contributed to the advancement of vaccine development. Read more >
Key Learnings From the Pharma & Healthcare Comms & Reputation Conference
In November, Alan Gray, VP of Sales and Client Success, attended a London-based event focusing on pharmaceutical communications and reputation. The conference brought together industry experts to talk about how goodwill was created during the pandemic and how pharma is navigating the challenges and opportunities of the ‘post-pandemic’ period. Here’s a brief summary of what was discussed.
Six tips when conducting cross-cultural research
Market Researchers have long realized the challenges of conducting research across cultures. Nuances in language or scales need to be considered during design, and cultural trends or tendencies need to be considered during interpretation. Read these six tips to improve your next research survey, and join our upcoming webinar to learn more and ask questions with methodology experts.
If you’d like to discuss in more detail how we work with our clients and, if you like our insights, we’d love to hear from you. Get in touch now!